Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | MPI | P34949 | 1/20 | 0.58 |
| ▸ | GPR84 | Q9NQS5 | 9/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | NQO1 | P15559 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.45 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.45 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29510114 | 1.00 | MEN1 (0.58) | MEN1KMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL30275493 | 1.00 | MEN1 (0.58) | MEN1KMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL2533194 | 0.94 | MEN1 (0.56) | MEN1KMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL14327785 | 0.91 | GPR84 (0.50) | MEN1KMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL29026237 | 0.90 | MEN1 (0.52) | MEN1KMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL19821130 | 0.90 | MEN1 (0.49) | MEN1KMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL14327758 | 0.89 | MEN1 (0.51) | MEN1KMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL2528988 | 0.88 | MEN1 (0.54) | MEN1KMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL13400328 | 0.87 | MEN1 (0.46) | MEN1KMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL3922384 | 0.86 | MEN1 (0.53) | MEN1KMT2AKDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534484-B2 | Process for preparing dimeric phosphazene derived BrØnsted acids | STUDIENGESELLSCHAFT KOHLE GGMBH (DE) | 2026-01-27 | — | — | US | disclosed |
| EP-4200308-B1 | PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS | STUDIENGESELLSCHAFT KOHLE GGMBH (DE) | 2025-09-10 | — | — | EP | disclosed |
| EP-3766913-B1 | POLYESTER RESIN OR POLYESTER CARBONATE RESIN, AND OPTICAL MEMBER USING SAID RESIN | TEIJIN LTD (JP) | 2025-04-30 | — | — | EP | disclosed |
| US-20240010834-A1 | THERMOPLASTIC RESIN AND OPTICAL MEMBER INCLUDING SAME | TEIJIN LIMITED (JP) | 2024-01-11 | — | — | US | disclosed |
| US-20230406870-A1 | PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS | STUDIENGESELLSCHAFT KOHLE GGMBH (DE) | 2023-12-21 | — | — | US | disclosed |
| CN-116348435-A | Process for preparing dimeric phosphazene-derived bronsted acids | 科勒研究非盈利有限责任公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-113788857-B | Phosphate ligand, preparation method and application thereof in preparation of linear aldehyde by catalyzing hydroformylation of terminal olefin | 万华化学集团股份有限公司 | 2023-03-03 | — | — | CN | disclosed |
| US-11566102-B2 | Polyester resin or polyester carbonate resin, and optical member using said resin | TEIJIN LIMITED (JP) | 2023-01-31 | — | — | US | disclosed |
| WO-2022091780-A1 | THERMOPLASTIC RESIN AND OPTICAL MEMBER INCLUDING SAME | 帝人株式会社 | 2022-05-05 | — | — | WO | disclosed |
| EP-3981775-A1 | PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS | Studiengesellschaft Kohle mbH (DE) | 2022-04-13 | — | — | EP | disclosed |
| EP-1268584-B1 | COMPOSITIONS AND METHODS FOR SELECTIVELY BINDING AMINES OR AMINO ACID ENANTIOMERS OVER THEIR COUNTER-ENANTIOMERS | IBC ADVANCED TECH INC (US) | 2010-05-05 | — | — | EP | disclosed |
| EP-1341797-A4 | ORTHO SUBSTITUTED CHIRAL PHOSPHINES AND PHOSPHINITES AND THEIR USE IN ASYMMETRIC CATAYLTIC REACTIONS | PENN STATE RES FOUND (US) | 2005-06-15 | — | — | EP | disclosed |
| US-6855657-B2 | Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions | THE PENN STATE RESEARCH FOUNDATION (US) | 2005-02-15 | — | — | US | disclosed |
| US-20040068126-A1 | Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions | THE PENN STATE RESEARCH FOUNDATION | 2004-04-08 | — | — | US | disclosed |
| US-6686479-B2 | SEPARATION OF ENANTIOMORPHS | IBC ADVANCED TECHNOLOGIES, INC. | 2004-02-03 | — | — | US | disclosed |
| US-6653485-B2 | Particularly effective in Ru-catalyzed asymmetric hydrogenation of beta-ketoesters to beta-hydroxyesters and ruthenium-catalyzed asymmetric hydrogenation of enamides to beta amino acids; catalyst selectivity | THE PENN STATE RESEARCH FOUNDATION | 2003-11-25 | — | — | US | disclosed |
| EP-1341797-A1 | ORTHO SUBSTITUTED CHIRAL PHOSPHINES AND PHOSPHINITES AND THEIR USE IN ASYMMETRIC CATAYLTIC REACTIONS | THE PENN STATE RESEARCH FOUNDATION (US) | 2003-09-10 | — | — | EP | disclosed |
| US-20020128501-A1 | Particularly effective in Ru-catalyzed asymmetric hydrogenation of beta-ketoesters to beta-hydroxyesters and ruthenium-catalyzed asymmetric hydrogenation of enamides to beta amino acids; catalyst selectivity | THE PENN STATE RESEARCH FOUNDATION | 2002-09-12 | — | — | US | disclosed |
| WO-2002040491-A1 | ORTHO SUBSTITUTED CHIRAL PHOSPHINES AND PHOSPHINITES AND THEIR USE IN ASYMMETRIC CATAYLTIC REACTIONS | THE PENN STATE RESEARCH FOUNDATION (US) | 2002-05-23 | — | — | WO | disclosed |
| US-20020019491-A1 | Compositons and methods for selectively binding amines or amino acid enantiomers over their counter-enantiomers | IBC ADVANCED TECHNOLOGIES, INC. | 2002-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040068126-A1 | Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions | BCKDK, PDK3, HCK | MEN1 1900/4885KMT2A 975/4885KDM4E 2838/4885 |
| US-20020128501-A1 | Particularly effective in Ru-catalyzed asymmetric hydrogenation of beta-ketoesters to beta-hydroxyesters and ruthenium-catalyzed asymmetric hydrogenation of enamides to beta amino acids; catalyst selectivity | HRH4, BCKDK, HRH3 | MEN1 2086/4885KMT2A 1234/4885KDM4E 2902/4885 |
| US-20230406870-A1 | PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS | PHOSPHO1, BRPF1, BRD9 | MEN1 786/4885KMT2A 1165/4885KDM4E 3341/4885 |
| US-12534484-B2 | Process for preparing dimeric phosphazene derived BrØnsted acids | HAT1, LBR, CD79B | MEN1 2901/4885KMT2A 1556/4885KDM4E 2895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.